Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens

Sara W. Quist*, Sophie te Dorsthorst, Roel D. Freriks, Maarten J. Postma, Carel B. Hoyng, Freekje van Asten

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology